How to Store Fragile Biological Materials Without Refrigeration
A method for preserving unstable biological materials like proteins by trapping them in a solid, glass-like sugar or polymer matrix that prevents decay at room temperature.
Patent Number
US RE39497
Status
Active
Filing Date
August 28, 2001
Grant Date
February 27, 2007
Expiration
~August 2021 (estimated)
Claims
25
Assignee
Nektar Therapeutics
Inventors
Felix Franks, Ross H. M. Hatley
Citations
11 forward · 49 backward
What it covers
This patent describes a way to keep delicate biological materials, such as proteins or enzymes, from breaking down when they are not kept in a fridge. It works by dissolving the fragile material into a water-soluble carrier, like a sugar or a synthetic polymer, and then turning that mixture into a solid, glassy, amorphous state. Because the material is locked inside this rigid 'glass,' it cannot move or react, effectively pausing its degradation at room temperature. When a scientist needs to use the material again, they simply add water to dissolve the glass and release the active substance.
What it doesn't cover
- —Does not cover materials that are already stable in aqueous solution at room temperature.
- —Does not cover storage methods that rely on freezing or standard refrigeration.
- —Does not cover the storage of rennin specifically, as it is explicitly excluded in claim 17.
- —Does not cover liquid-state storage solutions that do not form a glassy amorphous solid.
The clever bit
The innovation lies in using the glass transition state of a sugar or polymer matrix to physically immobilize molecules, preventing the molecular movement necessary for chemical degradation without needing to lower the temperature.
Why it matters
This technology is vital for the pharmaceutical and biotech industries, where shipping temperature-sensitive medicines like vaccines or therapeutic proteins is expensive and logistically difficult. By removing the need for a 'cold chain'—the continuous refrigeration of products from factory to patient—this method reduces costs and increases access to life-saving drugs in regions lacking reliable electricity.
Real-world examples
- 1.Lyophilized (freeze-dried) protein therapeutics
- 2.Room-temperature stable diagnostic test reagents
- 3.Stabilized enzyme formulations for industrial use
Generated by PatentBrief · Not legal advice · patentbrief.org
US RE39497 · 2026